September 8, 1993, Vol 270, No. 10 >

< Previous Article Next Article >

ARTICLE | September 8, 1993

Prehospital-Initiated vs Hospital-Initiated Thrombolytic Therapy: Title and subTitle BreakThe Myocardial Infarction Triage and Intervention Trial FREE

W. Douglas Weaver, MD; Manuel Cerqueira, MD; Alfred P. Hallstrom, PhD; Paul E. Litwin, MS; Jenny S. Martin, RN; Peter J. Kudenchuk, MD; Mickey Eisenberg, MD

[+] Author Affiliations

A complete list of the organizational committee members and individual investigators may be found in Weaver WD, Eisenberg MS, Martin JS, et al. Myocardial Infarction Triage and Intervention Project—phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol. 1990;15:925-931.

Presented in part at the scientific sessions of the American College of Cardiology annual meeting, Dallas, Tex, April 15, 1992.

Reprint requests to Myocardial Infarction Triage and Intervention Trial Project Coordinating Center, 1910 Fair-view Ave E, Suite 205, Seattle, WA 98102 (Dr Weaver).

JAMA. 1993;270(10):1211-1216. doi:10.1001/jama.1993.03510100061033

Text Size: A A A

Published online

Article

References

ABSTRACT

ABSTRACT | REFERENCES

Objective. —To determine the effect of prehospital-initiated vs hospital-initiated treatment of myocardial infarction on clinical outcome.

Design. —Randomized, controlled clinical trial.

Setting. —Multicenter study involving 19 hospitals and all paramedic systems in the Seattle, Wash, metropolitan area.

Patients. —A total of 360 patients with symptoms for 6 hours or less, no risk factors for serious bleeding, and ST-segment elevation were selected by paramedics and a remote physician for inclusion into the trial. They represented 4% of patients with chest pain who were screened and 21% of those with acute infarction.

Interventions. —Patients were allocated to have aspirin and alteplase treatment initiated before or after hospital arrival. Intravenous sodium heparin was administered to both groups in the hospital.

Main Outcome Measure. —The primary endpoint was a ranked composite score (combining death, stroke, serious bleeding, and infarct size). The relation between time to treatment and outcome (composite score, infarct size, ejection fraction, and mortality) was also assessed.

Results. — Initiating treatment before hospital arrival decreased the interval from symptom onset to treatment from 110 to 77 minutes (P<.001). Although more patients whose therapy was initiated before hospital arrival had resolution of pain by admission (23% vs 7%; P<.001), there were no significant differences in the composite score (P=.64), mortality (5.7% vs 8.1%), ejection fraction (53% vs 54%), or infarct size (6.1% vs 6.5%). A secondary analysis of time to treatment and outcome showed that treatment initiated within 70 minutes of symptom onset was associated with better outcome (composite score, P=.009; mortality, 1.2% vs 8.7%, P=.04; infarct size, 4.9% vs 11.2%, P<.001; and ejection fraction, 53% vs 49%, P=.03) than later treatment. Identification of patients eligible for thrombolysis by paramedics reduced the hospital treatment time from 60 minutes (for patients not in the study) to 20 minutes (for study patients allocated to begin treatment in the hospital).

Conclusion. —There was no improvement in outcome associated with initiating treatment before hospital arrival; however, treatment within 70 minutes of symptom onset—whether in the hospital or in the field—minimized the infarct process and its complications.(JAMA. 1993;270:1211-1216)

REFERENCES

ABSTRACT | REFERENCES

Gruppo Italiano per lo Studio della Streptochinase nell' Infarto miocardio (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet . 1986;;1:397-402.

ISIS-2 (Second International Study of Infarct Survival Collaborative Group). Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet . 1988;;2:349-360.

Wilcox RG, Olsson CG, Skene AM, et al. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet . 1988;;2:525-530.

AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet . 1988;;1:545-549.

Koren G, Weiss AT, Hasin Y, et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med . 1985;;313:1384-1389.

Weaver WD, Eisenberg ME, Martin JS, et al. Myocardial Infarction Triage and Intervention Project—phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol . 1990;;15:925-931.

Kudenchuk PJ, Ho MT, Weaver WD, et al. Accuracy of computer-interpreted electrocardiography in selecting patients for thrombolytic therapy. J Am Coll Cardiol . 1991;;17:1486-1491.

Weaver WD, Kennedy JW. Myocardial infarction—thrombolytic therapy in the prehospital setting. In: Fuster V, Verstraete M, eds. Thrombosis in Cardiovascular Disorders . Philadelphia, Pa: Harcourt Brace & Co; 1992;:275-287.

Ritchie JL, Davis KB, Williams DL, et al. Global and regional left ventricular function and tomographic radionuclide perfusion: the Western Washington Intracoronary Streptokinase in Acute Myocardial Infarction Trial. Circulation . 1984;;70:867-875.

Caldwell JH, Williams DL, Harp GD, Stratton JR, Ritchie JL. Quantitation of size of relative myocardial perfusion defect by single-photon emission computed tomography. Circulation . 1984;;70:1048-1056.

Hallstrom AP, Litwin PE, Weaver WD. A method of assigning scores to the components of a composite outcome: an example from the MITI trial. Controlled Clin Trials . 1992;;13:148-155.

Aufderheide TP, Keelan MH, Hendley GE, et al. Milwaukee Prehospital Chest Pain Project—phase I: feasibility and accuracy of prehospital thrombolytic candidate selection. Am J Cardiol . 1992;;69:991-996.

Gibler WB, Kereiakes DJ, Dean EN, et al. Prehospital diagnosis and treatment of acute myocardial infarction: a North-South perspective. Am Heart J . 1991;;121:1-11.

Schofer J, Buttner J, Geng G, et al. Prehospital thrombolysis in acute myocardial infarction. Am J Cardiol . 1990;;66:1429-1433.

Varshavsky SY. Prehospital thrombolysis in acute myocardial infarction. Prehospital Disaster Med . 1992;;7:57-59.

Thrombolysis Early in Acute Heart Attack Trial Study Group. Very early thrombolytic therapy in suspected acute myocardial infarction. Am J Cardiol . 1990;;65:401-407.

Villemant D, Barriot P, Riou B, et al. Achievement of thrombolysis at home in cases of acute myocardial infarction. Lancet . 1987;;1:228-229.

Barbash GI, Roth A, Hod H, et al. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction. Am J Cardiol . 1990;;66:538-545.

Weiss AT, Fine DG, Applebaum D, et al. Prehospital coronary thrombolysis: a new strategy in acute myocardial infarction. Chest . 1987;;92:124-128.

Bossaert LL, Demey HE, Colemont LJ, et al. Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Crit Care Med . 1988;;16:823-830.

Bouten MJM. Snellere behandeling van het acute myoxardinfarct door toediening van alteplase (rTPA) voor opname. Ned Tijdschr Geneeskd . 1990;; 50:2434-2438.

McNeill AJ, Cunningham SR, Flannery DJ, et al. A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction. Br Heart J . 1989;;61:316-321.

Willem JL, Abreu-Lima C, Arnaud P, et al. The diagnostic performance of computer programs for the interpretation of electrocardiograms: diagnostic performance of ECG computer programs. N Engl J Med . 1991;:325:1767-1773.

Roth A, Barbash GI, Hod H, et al. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? J Am Coll Cardiol . 1990;;15:932-936.

Schmidt SB, Borsch MA. The prehospital phase of acute myocardial infarction in the era of thrombolysis. Am J Cardiol . 1990;;65:1411-1415.

Brugeman J, van der Meer J, de Graeff PA, Takens LH, Lie KI. Logistical problems in prehospital thrombolysis. Eur Heart J . 1992;;13:787-788.

Mayo E. The Human Problems of an Industrial Civilization . New York, NY: Macmillan Publishing Co Inc; 1933;.

Sharkey SW, Brunette DD, Ruiz E, et al. An analysis of time delays preceding thrombolysis for acute myocardial infarction. JAMA . 1989;;262:3171-3174.

Kereiakes DJ, Weaver WD, Anderson JL, et al. Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities: report from the Prehospital Study Group and the Cincinnati Heart Project. Am Heart J . 1990;;120:773-780.

Fine DG, Weiss AT, Sapoznikov D, et al. Importance of early initiation of intravenous streptokinase therapy for acute myocardial infarction. Am J Cardiol . 1986;;58:411-417.

Cerqueira MD, Maynard C, Ritchie JL. Radionuclide assessment of infarct size and left ventricular function in clinical trials of thrombolysis. Circulation . 1991;;84( (suppl I) ):100-108.

Pell CH, Miler HC, Robertson CE, Fox KA. Effect of'fast track' admission for acute myocardial infarction. BMJ . 1992;;304:83-87.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal